Early detection can lead to a safe cure
If based on preventive screening prostate cancer is suspected, samples of prostate tissue must be examined to make a formal diagnosis of the cancer. Controlled by ultrasound and after administering a preventive dose of antibiotics, under local anesthesia tissue samples are taken from different areas of the prostate. These tissue samples are then examined under the microscope by an experienced pathologist. Given the pathological result, the PSA level, and the palpation findings, an accurate prognoses indicating whether the cancer is confined to the prostate, can be made.
In the case of aggressive tumors (Gleason-Score greater than 6) or high PSA scores (above 10 ng/ml), repeated biopsies will reveal possible metastasis outside of the prostate.
Possible procedures include:
• Bone Scans
• Computer Tomography (CT)
• Magnetic Resonance Tomography (MRT)
• Lymph node dissection for microscopic examination
• Cholin Positron Emissions Tomography (Cholin PET)
All these procedures are helping to decide, whether the disease confined to the prostate, and whether a local, to the prostate confined therapy, can be recommended.
Following is an overview of the different forms of therapy.